Therapeutic Areas: Neurology | Psychiatry/Psychology | Musculoskeletal

Tardive Dyskinesia Clinical Trials

A listing of Tardive Dyskinesia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arkansas

Little Rock Arkansas 72211

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Florida

APG Research, LLC
Orlando Florida 32803

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Miami Springs Florida 33166

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Georgia

Decatur Georgia 30030

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Illinois

Naperville Illinois 60563

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Michigan

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Nebraska

Lincoln Nebraska 68526

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Oklahoma

Oklahoma City Oklahoma 73112

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Washington

Northwest Clinical Research Center
Bellevue Washington 98007

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Bellevue Washington 98007

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Canada

Toronto Ontario M5T 2S8

Patients are needed to participate in a clinical research study evaluating Transcranial ExAblate System

Japan

Aichi

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Aomori

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Chiba

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Fukuoka

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Fukushima

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Gifu

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Gunma

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Hiroshima

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Hokkaido

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Hyogo

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Kagoshima

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Kanagawa

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Kumamoto

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Kyoto

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Nagano

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Nara

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Osaka

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Saga

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Saitama

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Shimane

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Tokyo

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Toyama

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

Yamagata

A clinical trial to evaluate treatments using MT-5199 and Placebo for patients with Tardive Dyskinesia

 

 

 

 

Bipolar World   1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010
Owners:  Allie Bloom, David Schafer, M.Ed. (Blackdog)

Partners:  John Haeckel, Judith (Duff)
Founder:  Colleen Sullivan
Email Us at Bipolar World


About Us  Add a Link  Advance Directives  Alternative Treatments  Ask the Doctor   Ask Dr. Plyler about Bipolar Disorder   Ask The Doctor/Topic Archives  Awards  Benny the Bipolar Puppy  Bipolar Chat  Bipolar Children  Bipolar Disorder News  Bipolar Help Contract  Bipolar World Forums  Book Reviews  Bookstore  BP & Other mental Illness   Clinical Research Trials & FDA Drug Approval   Community Support   Contact Us  The Continuum of Mania and Depression   Coping   Criteria    Criteria and Diagnosis  Criteria-World Health Disabilities,  DSMV-IV   Dual Diagnosis  eGroups  Expressions (Poetry, Inspiration, Humor, Art Gallery, Memorials  Family Members   Getting Help for a Loved One who Refuses Treatment  Greeting Cards  History of Mental Illness  Indigo  Job and School  Links    Medications   Medication and Weight Gain    News of the Day  Parent Chat  Pay for Meds  Personal Stories  Self Help  Self Injury  Significant Others  Stigma and Mental Health Law  Storm's Column  Suicide!!!  The Suicide Wall  Table of Contents  Treatments  Treatment Compliance  US Disability  Veteran's Chat  What's New?